Drug Search Results
More Filters [+]

Itriglumide

Alternative Names: itriglumide
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: CCK Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Rottapharm S.p.A.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Itriglumide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Sleep Apnea, Obstructive

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2013-004469-15

P2

Completed

Sleep Apnea, Obstructive

2014-09-12

Recent News Events

Date

Type

Title